Login to Your Account



Not Viagra: Addyi nod serves up controversy

By Jennifer Boggs
Managing Editor

Wednesday, August 19, 2015

Advocacy groups lobbying for the approval of a therapeutic to treat sexual dysfunction in women celebrated victory late Tuesday with the agency's after-hours nod to Sprout Pharmaceuticals Inc.'s Addyi; however, by Wednesday afternoon, the critics were out in force.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription